Siemens Healthineers is a leading provider of medical technology, principally active in the areas of imaging, diagnostics, cancer care and minimally invasive therapies augmented by digital technology and artificial intelligence.
Siemens Healthineers
Company · Germany · EU Transparency Register 982823533509-58
Counts here are a floor, never a total: they cover the 326 consultation files tracked so far (29,503 submissions, mostly 2025–26), so an organization's real filing history is larger, not smaller.
Who they are
Among the 925 companies & groups on this site, they rank #56 by legislative files engaged — a count of participation, not a measure of influence.
Declares membership of
- Siemens Healthineers AG and its consolidated subsidiaries are represented in a large number of associations worldwide.
- The most important ones at EU level are: COCIR
- MedTechEurope →
- DigitalEurope. →
- Membership fees for these associations (proportionate to the estimated business activity of the associations mentione…
- We would like to point out that all information given and registered values relate only to Siemens Healthineers AG an…
Self-declared to the EU Transparency Register (snapshot 30 Aug 2026).
- Register category
- Companies & groups
- Registered as
- Siemens Healthineers AG (SHS)
- Head office
- Forchheim, Germany
- EU office
- Brussels
Self-declared to the EU Transparency Register (snapshot 30 Aug 2026); cost bands are floors, not audited totals. Reused under Commission Decision 2011/833/EU.
Track Siemens in PolicySpeak: request access →
Work at Siemens Healthineers? so we know who speaks for it.
Their record over time
Siemens Healthineers filed 9 positions between 7 Mar 2025 and 19 May 2026, across 9 of the 326 legislative files tracked here, attaching a full position paper 8 times.
What they argued
Siemens Healthineers would warmly welcome a review of the Public Procurement Directive (Directive 2014/24/EU). In order to secure the healthcare sector competitiveness and foster innovation, we have identified crucial points which we believe should be considered when further discussing the topic: Moving towards value-based procurement with value criteria being the most prominent aspect of the tenders and…
We appreciate the opportunity to contribute to the European Commissions targeted evaluation of the EU Medical Device Regulation (MDR, EU 2017/745) and In Vitro Diagnostic Regulation (IVDR, EU 2017/746). This initiative is critical to addressing structural challenges that have emerged since implementation and to ensuring that the regulatory framework continues to safeguard patient safety while supporting innovation…
Siemens Healthineers welcomes the European Commissions call for evidence on the EU public procurement rules which are key to our ecosystem. In order to secure the healthcare sector competitiveness and foster innovation, we have identified crucial points which we believe should be considered: Moving towards value-based procurement with value criteria being the most prominent aspect of the tenders rather than a…
Siemens Healthineers is a leading provider of medical technology, principally active in the areas of imaging, diagnostics, cancer care and minimally invasive therapies augmented by digital technology and artificial intelligence.
Siemens Healthineers welcomes the Commissions overarching objective to strengthen the Unions competitiveness while reducing unnecessary regulatory burdens, and at the same time ensuring a high level of cybersecurity and resilience across the EU.
Siemens Healthineers is a leading provider of medical technology, principally active in the areas of imaging, diagnostics, cancer care and minimally invasive therapies augmented by digital technology and artificial intelligence.
Siemens Healthineers appreciates the European Commissions ongoing efforts towards simplification of the CBAM, which should be maintained and further strengthened. We particularly welcome the introduction of the 50t de minimis threshold and the use of default values for emissions calculation, both of which are essential in reducing unnecessary administrative burdens for companies and ensuring proportionality.
Siemens Healthineers welcomes the European Commissions Call for Evidence on cardiovascular health checks and strongly supports the development of an EU-level protocol under the Safe Hearts Plan. Cardiovascular diseases, including stroke, remain the leading cause of death in the EU and continue to place a significant burden on citizens, health systems and economies.
Looking for an argument rather than an organization? Search every submission for a phrase and see everyone who used it.
Turns up on the same files
Organizations that also filed on at least two of the same consultations. A shared interest in the same dossiers — not evidence of coordination, and we do not suggest any.
- MedTech Europe · 8 files in common
- Cefic · 6 files in common
- EDF - Electricité de France · 6 files in common
- APPLiA - Home Appliance Europe · 6 files in common
- Royal Philips · 6 files in common
Showing 5 of 437.
Is this your organization?
Everything on this page comes from Siemens Healthineers’s own submissions to the European Commission — we have added nothing and interpreted nothing. If something is wrong or out of date, email info@policyspeak.com and we will correct it. If you are an individual named in a record, our privacy policy sets out your rights to correction, objection and removal.
Quotes are verbatim from submissions published by the European Commission, trimmed to their opening passage and never summarized by a model. Organizations only, never individuals. Reused under Commission Decision 2011/833/EU; the European Commission is not liable for this reuse.